Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Neurocrine Biosciences (NBIX) Interest Coverage Ratio (2017 - 2024)

Neurocrine Biosciences (NBIX) has disclosed Interest Coverage Ratio for 7 consecutive years, with 90.27 as the latest value for Q1 2024.

  • For the quarter ending Q1 2024, Interest Coverage Ratio rose 186.95% year-over-year to 90.27, compared with a TTM value of 518.64 through Dec 2024, up 354.76%, and an annual FY2019 reading of 2.26, up 1405.17% over the prior year.
  • Interest Coverage Ratio was 90.27 for Q1 2024 at Neurocrine Biosciences, down from 128.36 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 128.36 in Q3 2023 and bottomed at 103.82 in Q1 2023.
  • Average Interest Coverage Ratio over 4 years is 16.42, with a median of 7.18 recorded in 2020.
  • The sharpest move saw Interest Coverage Ratio crashed 146.28% in 2020, then skyrocketed 229.37% in 2021.
  • Year by year, Interest Coverage Ratio stood at 5.21 in 2020, then surged by 229.37% to 6.74 in 2021, then soared by 1803.82% to 128.36 in 2023, then dropped by 29.67% to 90.27 in 2024.
  • Business Quant data shows Interest Coverage Ratio for NBIX at 90.27 in Q1 2024, 128.36 in Q3 2023, and 103.82 in Q1 2023.